Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Gastric Cancer

  Free Subscription


Articles published in Cancer Lett

Retrieve available abstracts of 37 articles:
HTML format
Text format



Single Articles


    May 2018
  1. DING M, Wang H, Qu C, Xu F, et al
    Pyrazolo[1,5-a]pyrimidine TRPC6 Antagonists for the Treatment of Gastric Cancer.
    Cancer Lett. 2018 May 31. pii: S0304-3835(18)30380.
    PubMed     Text format     Abstract available


  2. MIN A, Eun Kim J, Kim YJ, Min Lim J, et al
    Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells.
    Cancer Lett. 2018 May 2. pii: S0304-3835(18)30310.
    PubMed     Text format     Abstract available


    January 2018
  3. QIAO Y, Li T, Zheng S, Wang H, et al
    The Hippo pathway as a drug target in gastric cancer.
    Cancer Lett. 2018 Jan 30. pii: S0304-3835(18)30095.
    PubMed     Text format     Abstract available


  4. MANU KA, Shanmugam MK, Ramachandran L, Li F, et al
    Corrigendum on "Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-kappaB signaling cascade in gastric cancer" [Cancer Lett. 363 (1) (2015) 28-36].
    Cancer Lett. 2018 Jan 13. pii: S0304-3835(18)30025.
    PubMed     Text format    


  5. YUAN H, Chen Z, Bai S, Wei H, et al
    Molecular mechanisms of lncRNA SMARCC2/miR-551b-3p/TMPRSS4 axis in gastric cancer.
    Cancer Lett. 2018 Jan 11. pii: S0304-3835(18)30054.
    PubMed     Text format     Abstract available


    November 2017
  6. YANG L, Zhang W, Wang Y, Zou T, et al
    Hypoxia-induced miR-214 expression promotes tumour cell proliferation and migration by enhancing the Warburg effect in gastric carcinoma cells.
    Cancer Lett. 2017 Nov 9. pii: S0304-3835(17)30701.
    PubMed     Text format     Abstract available


    October 2017
  7. ZENG S, Xie X, Xiao YF, Tang B, et al
    Long noncoding RNA LINC00675 enhances phosphorylation of vimentin on Ser83 to suppress gastric cancer progression.
    Cancer Lett. 2017;412:179-187.
    PubMed     Text format     Abstract available


  8. DAS K, Taguri M, Imamura H, Sugimoto N, et al
    Genomic Predictors of Chemotherapy Efficacy in Advanced or Recurrent Gastric Cancer in the GC0301/ TOP002 Phase III Clinical Trial.
    Cancer Lett. 2017 Oct 20. pii: S0304-3835(17)30645.
    PubMed     Text format     Abstract available


  9. WU QN, Liao YF, Lu YX, Wang Y, et al
    Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance.
    Cancer Lett. 2017 Oct 16. pii: S0304-3835(17)30631.
    PubMed     Text format     Abstract available


  10. CHEN J, Li GQ, Zhang L, Tang M, et al
    Complement C5a/C5aR pathway potentiates the pathogenesis of gastric cancer by down-regulating p21 expression.
    Cancer Lett. 2017 Oct 12. pii: S0304-3835(17)30626.
    PubMed     Text format     Abstract available


  11. GUO W, You X, Wang X, Wang L, et al
    A synthetic peptide hijacks the catalytic subunit of class I PI3K to suppress the growth of cancer cells.
    Cancer Lett. 2017;405:1-9.
    PubMed     Text format     Abstract available


    September 2017
  12. LI B, Wang W, Li Z, Chen Z, et al
    MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression.
    Cancer Lett. 2017 Sep 28. pii: S0304-3835(17)30596.
    PubMed     Text format     Abstract available


  13. LI Y, Huang S
    Response to Comment on response to "Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer," Cancer Lett. 2017 Mar 1; 388(2017): 208-219.
    Cancer Lett. 2017 Sep 26. pii: S0304-3835(17)30553.
    PubMed     Text format    


    August 2017
  14. ZHANG J, Zhu J
    Comment on response to "Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer," Cancer Lett. 2017 Mar 1; 388(2017): 208-219.
    Cancer Lett. 2017 Aug 26. pii: S0304-3835(17)30505.
    PubMed     Text format    


  15. MA DH, Li BS, Liu JJ, Xiao YF, et al
    miR-93-5p/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway.
    Cancer Lett. 2017 Aug 24. pii: S0304-3835(17)30504.
    PubMed     Text format     Abstract available


  16. WANG ZQ, He CY, Hu L, Shi HP, et al
    Long noncoding RNA UCA1 promotes tumour metastasis by inducing GRK2 degradation in gastric cancer.
    Cancer Lett. 2017 Aug 23. pii: S0304-3835(17)30490.
    PubMed     Text format     Abstract available


  17. NORONHA V, Patil VM, Joshi A, Chougule A, et al
    Potential role of metronomic chemotherapy in the treatment of esophageal and gastroesophageal cancer.
    Cancer Lett. 2017;400:267-275.
    PubMed     Text format     Abstract available


    July 2017
  18. RIBEIRO J, Malta M, Galaghar A, Silva F, et al
    P53 deregulation in Epstein-Barr virus-associated gastric cancer.
    Cancer Lett. 2017;404:37-43.
    PubMed     Text format     Abstract available


    June 2017
  19. DENG M, Zeng C, Lu X, He X, et al
    miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
    Cancer Lett. 2017 Jun 17. pii: S0304-3835(17)30387.
    PubMed     Text format     Abstract available


    May 2017
  20. LI Y, Huang S
    Response to "Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer," Cancer Lett. 2017 Mar 1; 388(2017): 208-219.
    Cancer Lett. 2017 May 30. pii: S0304-3835(17)30330.
    PubMed     Text format    


  21. SUN Z, Liu J, Zhou Q, Yang S, et al
    Comment on "Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer," Cancer Lett. 2017 Mar 1; 388(2017): 208-219.
    Cancer Lett. 2017 May 20. pii: S0304-3835(17)30331.
    PubMed     Text format    


    April 2017
  22. GEN Y, Yasui K, Kitaichi T, Iwai N, et al
    ASPP2 suppresses invasion and TGF-beta1-induced epithelial-mesenchymal transition by inhibiting Smad7 degradation mediated by E3 ubiquitin ligase ITCH in gastric cancer.
    Cancer Lett. 2017 Apr 8. pii: S0304-3835(17)30232.
    PubMed     Text format     Abstract available


    March 2017
  23. LI Y, Wu Z, Yuan J, Sun L, et al
    Long non-coding RNA MALAT1 promotes gastric cancer tumorigenicity and metastasis by regulating vasculogenic mimicry and angiogenesis.
    Cancer Lett. 2017 Mar 4. pii: S0304-3835(17)30152.
    PubMed     Text format     Abstract available


    February 2017
  24. FERREIRA JA, Magalhaes A, Gomes J, Peixoto A, et al
    Protein glycosylation in gastric and colorectal cancers: Toward cancer detection and targeted therapeutics.
    Cancer Lett. 2017;387:32-45.
    PubMed     Text format     Abstract available


  25. XU L, Zhou R, Yuan L, Wang S, et al
    IGF1/IGF1R/STAT3 signaling-inducible IFITM2 promotes gastric cancer growth and metastasis.
    Cancer Lett. 2017 Feb 18. pii: S0304-3835(17)30122.
    PubMed     Text format     Abstract available


  26. WU H, Liu S, Gong J, Liu J, et al
    VCPA, a novel synthetic derivative of alpha-tocopheryl succinate, sensitizes human gastric cancer to doxorubicin-induced apoptosis via ROS-dependent mitochondrial dysfunction.
    Cancer Lett. 2017 Feb 16. pii: S0304-3835(17)30107.
    PubMed     Text format     Abstract available


    January 2017
  27. TSAI MM, Wang CS, Tsai CY, Chen CY, et al
    Corrigendum to "MicroRNA-196a/-196b promote cell metastasis via negative regulation of radixin in human gastric cancer" [Cancer Lett 351 (2014) 222-231].
    Cancer Lett. 2017 Jan 27. pii: S0304-3835(17)30071.
    PubMed     Text format    


    December 2016
  28. MI Y, Zhang D, Jiang W, Weng J, et al
    miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation.
    Cancer Lett. 2016 Dec 30. pii: S0304-3835(16)30803.
    PubMed     Text format     Abstract available


  29. CHEN J, Li Y, Zheng Q, Bao C, et al
    Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer.
    Cancer Lett. 2016;388:208-219.
    PubMed     Text format     Abstract available


    November 2016
  30. YUAN W, Liu B, Wang X, Li T, et al
    CMTM3 decreases EGFR expression and EGF-mediated tumorigenicity by promoting Rab5 activity in gastric cancer.
    Cancer Lett. 2016 Nov 17. pii: S0304-3835(16)30703.
    PubMed     Text format     Abstract available


  31. LI R, Liu B, Gao J
    The application of nanoparticles in diagnosis and theranostics of gastric cancer.
    Cancer Lett. 2016 Nov 11. pii: S0304-3835(16)30663.
    PubMed     Text format     Abstract available


  32. WANG Z, Wang Z, Li G, Wu H, et al
    CXCL1 from tumor-associated lymphatic endothelial cells drives gastric cancer cell into lymphatic system via activating integrin beta1/FAK/AKT signaling.
    Cancer Lett. 2016;385:28-38.
    PubMed     Text format     Abstract available


    October 2016
  33. HWANG DW, Bang NY, Ito K, Ha S, et al
    In vivo targeting of c-Met using a non-standard macrocyclic peptide in gastric carcinoma.
    Cancer Lett. 2016 Oct 31. pii: S0304-3835(16)30661.
    PubMed     Text format     Abstract available


  34. PENG Y, Zhang X, Ma Q, Yan R, et al
    MiRNA-194 activates the Wnt/beta-catenin signaling pathway in gastric cancer by targeting the negative Wnt regulator, SUFU.
    Cancer Lett. 2016 Oct 31. pii: S0304-3835(16)30666.
    PubMed     Text format     Abstract available


  35. WANG JB, Wang ZW, Li Y, Huang CQ, et al
    CDK5RAP3 acts as a tumor suppressor in gastric cancer through inhibition of beta-catenin signaling.
    Cancer Lett. 2016 Oct 25. pii: S0304-3835(16)30645.
    PubMed     Text format     Abstract available


    July 2016
  36. DU Y, Yu J, Du L, Tang J, et al
    Cordycepin enhances Epstein-Barr virus lytic infection and Epstein-Barr virus-positive tumor treatment efficacy by doxorubicin.
    Cancer Lett. 2016;376:240-8.
    PubMed     Text format     Abstract available


    June 2016
  37. HOU J, Wang T, Xie Q, Deng W, et al
    N-Myc-interacting protein (NMI) negatively regulates epithelial-mesenchymal transition by inhibiting the acetylation of NF-kappaB/p65.
    Cancer Lett. 2016;376:22-33.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: